Artificial Intelligence
Global Arthroscopy Devices Market Size, Share & Industry Trends Analysis Report By Type, By Application, By Regional Outlook and Forecast, 2022 – 2028
New York, June 10, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Arthroscopy Devices Market Size, Share & Industry Trends Analysis Report By Type, By Application, By Regional Outlook and Forecast, 2022 – 2028” – https://www.reportlinker.com/p06283395/?utm_source=GNW
Arthroscopy devices can look for illnesses like osteoarthritis, rheumatoid arthritis, tendonitis, and bone tumors in the joints. Furthermore, the use of arthroscopy devices has increased as the frequency of sports-related injuries and the number of sports tournaments has increased. Furthermore, the need for intrusive therapies is increasing across the world. Also, technological improvements have allowed arthroscopy devices to be used for a wide range of bone and joint disorders, resulting in a significant arthroscopy devices market opportunity.
As per the World Health Organization, there were 1 billion persons aged 60 and more in 2019, with that number predicted to rise to 1.4 billion by 2030 and 2.1 billion by 2050. As a result, the number of patients with musculoskeletal diseases will rise, which will increase the demand for arthroscopy instruments. Furthermore, 1.71 billion individuals will be affected by musculoskeletal diseases by 2021, making it the biggest cause of disability worldwide. As a result, medical gadgets that can efficiently test and treat bone and joint disorders are in high demand.
Moreover, in emerging economies, spending on healthcare facilities is rapidly expanding. According to the India Brand Equity Foundation, India’s hospital business is predicted to reach approximately $372 billion in FY22, up from $61.79 billion in FY17, indicating a CAGR of roughly 16–17%. In addition, the use of arthroscopy devices allows patients to recover quickly and with few consequences.
COVID-19 Impact
COVID-19 virus quickly spread throughout several countries and regions, wreaking havoc on people’s lives and the community as a whole. It started as a human health issue and has since evolved into a major threat to global trade, economics, and finance. The pandemic of COVID-19 raised the relevance of government healthcare facilities, resulting in increased healthcare spending around the world. Furthermore, once the COVID-19 vaccine becomes available, the number of cases is projected to decrease. This has resulted in the reopening of full-scale research labs for arthroscopy devices. This will aid the market get back on the path to recovery by the beginning of 2022. Companies that make medical equipment must concentrate on safeguarding their employees, operations, and supply networks in order to respond to immediate circumstances and build new working practices after a pandemic.
Market Growth Factors
High Cases of Joint Replacement Surgery
The arthroscopy devices market is growing due to the rising demand for joint replacement surgeries across various regions. Hundreds of thousands of joint replacement surgeries are conducted in developed regions such as North America and Europe. The healthcare segment in these regions is developed and governments in these nations put an emphasis on the adoption of the latest devices, thus pushing the adoption of the latest arthroscopy devices. Growth in the geriatric population is leading to an increase in the cases of the knee and joint-related disorders since the elderly are more vulnerable to these diseases.
Technological Developments in the Arthroscopy Devices
The rising demand for arthroscopic gadgets in sports medicine is expected to present significant possibilities for market competitors. Manufacturers are working on arthroscopy equipment with high-definition cameras, improved suturing procedures, and specialized suturing materials to improve visualization. Arthroscopy devices improved the image qualoity from high definition to 4K. Surgical center leaders started to understand the many advantages of the improved image quality provided by 4K imaging. While regular high-definition imaging is undoubtedly good, there is a significant difference when they upgraded to 4K. With the help of 4K, pathology can be identified, exact measurements taken, diseases treated, and arthroscopic surgery performed with improved precision.
Market Restraining Factors
Negative Consequence of the Arthroscopy surgeries
Swelling is one of the most common symptoms of joint inflammation before any surgical treatment. Following surgery, knee swelling can sometimes remain and even increase. Swelling can happen as a consequence of prolonged inflammation, hemorrhage, or infection within the joint. Resting the knee joint, applying ice, wearing an elastic bandage, and raising the extremities are all methods for reducing swelling. However, for some patients, swelling persists after arthroscopic surgery, which can be a bothersome cause of discomfort. Swelling that becomes worse can be an indication of something more severe issues. The creation of scar tissue surrounding the knee joint, as well as prolonged inflammation of the knee joint, can cause stiffness in the knee joint.
Type Outlook
Based on Type, the market is segmented into Arthroscopes, Arthroscopic Implants, Radiofrequency Systems, Fluid Management Systems, Visualization Systems, Powered Shavers, and Others. The arthroscopic implants segment procured a substantial revenue share in the arthroscopy devices market in 2021. It is due to the availability of smart and personalized implants, arthroscopic implants have seen widespread acceptance in arthroscopic surgeries, providing lucrative market growth potential. These implants are effective for diaphyseal/metaphyseal reduction since they are designed to fit nicely and need little or no further bending. The demand for arthroscopic implants in internal tissue repair, bone grafting, joint fixation, and glenoid reconstruction has been boosted by the introduction of biodegradable implants and the demand for arthroscopic implants in internal tissue repair, bone grafting, joint fixation, and glenoid reconstruction.
Application Outlook
Based on Application, the market is segmented into Knee Arthroscopy, Hip Arthroscopy, Shoulder & Elbow Arthroscopy, and Others. The knee arthroscopy segment acquired the largest revenue share in the arthroscopy devices market in 2021. This occurred as a result of an increase in the number of patients suffering from bone illnesses like arthritis. The rise in the senior population and the amount of sports-related injuries are driving market expansion. A tiny camera is inserted into the knee joint during knee arthroscopy. The surgeon uses the images from the camera to control microscopic surgical instruments, which are displayed on a television monitor. Degenerative knee disease is a worldwide occurrence among the elderly that is becoming more common as the worldwide geriatric population grows. According to the World Health Organization, roughly 25% of persons over the age of 50 suffer from degenerative knee disease, which causes knee discomfort. The pain is debilitating, and a knee replacement treatment is frequently the last and only option for relief.
Regional Outlook
Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. North America acquired the largest revenue share of the arthroscopy devices market in 2021. Due to the rising frequency of bone-related ailments, which is predicted to raise demand for diagnostic testing devices such as arthroscopes, North America is expected to keep a prominent position in the arthroscopy device market throughout the forecast period. According to data published by the Centers for Disease Control and Prevention (CDC) in 2017, approximately 54.4 million persons in the United States had arthritis or rheumatoid arthritis between 2013 and 2015. By 2040, this population is predicted to rise to roughly 78 million.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Johnson & Johnson, Smith & Nephew PLC, ConMed Corporation, Stryker Corporation, Zimmer Biomet Holdings, Inc., Karl Storz SE & Co. KG, Arthrex, Inc., Richard Wolf GmbH, and Henke Sass Wolf GmbH.
Strategies deployed in Arthroscopy Devices Market
Aug-2021: Zimmer Biomet Holdings and Canary Medical received FDA approval for Persona IQ, the world’s foremost smart knee cleared by the FDA for complete knee replacement surgery. Persona IQ provides a plethora of objective data to track patients’ post-operative progress. The release of Persona IQ marked the beginning of an enthralling, continuous partnership between Zimmer Biomet Holdings and Canary Medical to create smart implant technologies that assist joint replacement patients to retrieve and maintain their mobility with conviction.
Jul-2021: Stryker received FDA approval for its InSpace balloon, the first balloon implant for arthroscopic treatment of massive irreparable rotator cuff tears (MIRCTs). The InSpace balloon implant is developed to reinstate the subacromial space without needing sutures or fixation devices and has been demonstrated to enhance shoulder movement and function.
Jun-2021: DePuy Synthes entered into an agreement with Navbit, an Australian start-up company. As per the agreement, DePuy Synthes introduced Navbit Sprint into operating theatres across Australia. The agreement considered a tremendous opportunity to support an Australian medical innovation, while simultaneously introducing a doctor and patient-centric solution to the market.
Dec-2020: Arthrex launched SwiveLock ACL Repair Kit. This kit has received approval from the U.S. Food and Drug Administration for the SwiveLock anchor for ACL repair. In addition, SwiveLock ACL Repair Kit is the first kit designed especially for ACL repair.
Nov-2020: Medtronic acquired Medicrea International, a French firm and a key supplier of spinal implants and instruments bringing advanced digital tools to the surgery suite. Medicrea led the development of spinal surgery through “artificial intelligence (AI), predictive modeling, and patient-specific implants.” The acquisition brought 30 CE Marked or 510(k) cleared spinal implant technologies to Medtronic.
Sep-2020: Smith+Nephew acquired the Extremity Orthopaedics business of Integra LifeSciences Holdings Corporation, a key player in regenerative technologies, neurosurgical and extremity orthopedic solutions devoted to limiting uncertainty for clinicians. The acquisition aimed to strengthen Smith+Nephew’s extremities business substantially by adding an amalgamation of complementary shoulder replacement and upper and lower extremities portfolio, a focused sales channel, and an enthralling new product pipeline.
Aug-2020: CONMED entered into a partnership with PrecisionOS Technology, a company that made the first-of-its-kind arthroscopy simulator available on a compact, wireless device (Oculus Quest). The simulator was utilized by CONMED International for surgeon training. The partnership aimed at expanding rapidly across the globe in training surgeons on this complex procedure.
Jan-2020: Smith+Nephew completed the acquisition of Engage Surgical, a company that owned the only cementless unicompartmental (partial) knee system commercially available in the US. The acquisition aimed to propel Smith+Nephew’s Robotics and Real Intelligence strategy. Partial knee procedures are complementary to robotics due to the need for accurate calibration and Smith+Nephew’s CORI Surgical System already supports the cemented JOURNEY II? unicompartmental knee.
Mar-2019: Stryker released HipCheck, HipMap, the 1688 Advanced Imaging Modalities (AIM) 4K Visualization Platform, and the Connected OR Hub. The HipCheck platform is centered on developing the area of hip arthroscopy as an interactive tablet integrating into the existing OR workflow. The 1688 AIM 4K Platform highlights numerous improvements like spectacular 4K resolution and fluorescence, auto-light technology, enhanced ergonomics, and seamless standardization. The Connected OR Hub assists in enhancing standardization in the operating room, Stryker’s Connected OR Hub permits seamless connectivity between devices.
Oct-2018: Johnson & Johnson Medical acquired Emerging Technologies, a company involved in the design of 3-D printed titanium interbody implants for spinal fusion surgery. The take-over helped DePuy Synthes, the orthopedic business of Johnson & Johnson, to improve an interbody implant portfolio that includes expandable interbody devices, titanium integrated polyetheretherketone technology, and would consist of 3-D printed cellular titanium for both marginally invasive and open spinal surgery.
Sep-2018: Stryker completed the acquisition of Invuity, a leader in advanced photonics and single-use, lighted instruments. With the acquisition, Stryker gained Invuity’s innovative products in the single-use lighted instrumentation and improved energy markets, which offer best in class illumination and make surgery safer.
Scope of the Study
Market Segments covered in the Report:
By Type
• Arthroscopes
• Arthroscopic Implants
• Radiofrequency Systems
• Fluid Management Systems
• Visualization Systems
• Powered Shavers
• Others
By Application
• Knee Arthroscopy
• Hip Arthroscopy
• Shoulder & Elbow Arthroscopy
• Others
By Geography
• North America
o US
o Canada
o Mexico
o Rest of North America
• Europe
o Germany
o UK
o France
o Russia
o Spain
o Italy
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Singapore
o Malaysia
o Rest of Asia Pacific
• LAMEA
o Brazil
o Argentina
o UAE
o Saudi Arabia
o South Africa
o Nigeria
o Rest of LAMEA
Companies Profiled
• Medtronic PLC
• Johnson & Johnson
• Smith & Nephew PLC
• ConMed Corporation
• Stryker Corporation
• Zimmer Biomet Holdings, Inc.
• Karl Storz SE & Co. KG
• Arthrex, Inc.
• Richard Wolf GmbH
• Henke Sass Wolf GmbH
Unique Offerings
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free
Read the full report: https://www.reportlinker.com/p06283395/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
__________________________
Artificial Intelligence
More than $9 Million Awarded to High School Scientists and Engineers at the Regeneron International Science and Engineering Fair 2024
Grace Sun, 16, receives $75,000 Top Award for a new kind of organic electrochemical transistor at the world’s largest pre-college science, technology, engineering and math (STEM) competition.
TARRYTOWN, N.Y. and WASHINGTON, May 17, 2024 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Society for Science (the Society) announced that Grace Sun, 16, of Lexington, Kentucky, won the $75,000 top award, the George D. Yancopoulos Innovator Award, named in honor of the pioneering drug researcher and Regeneron co-Founder, Board co-Chair, President and Chief Scientific Officer, in the 2024 Regeneron International Science and Engineering Fair (Regeneron ISEF), the world’s largest pre-college science and engineering competition. Other top prizes went to projects in second-order cone programming, microplastics filtration and multi-sensory therapy for dementia.
The top winners were honored during two award ceremonies: the Special Awards on May 16 and the Grand Awards Ceremony on the morning of May 17. In total, over $9 million USD was awarded to the finalists based on their projects’ creativity, innovation and depth of scientific inquiry. The competition featured nearly 2,000 young scientists representing 49 U.S. states and nearly 70 countries, regions and territories across the world.
Grace Sun, 16, of Lexington, Kentucky, won first place and received the $75,000 George D. Yancopoulos Innovator Award for her research on building a better organic electrochemical transistor that she hopes will be used to develop new electronic devices that could help detect and treat serious illnesses like diabetes, epilepsy and organ failure. To overcome the problems that have previously prevented such devices from working effectively inside the body, Grace developed a new way of chemically treating their organic components, which greatly improved their laboratory performance.
Michelle Wei, 17, of San Jose, California, received one of two Regeneron Young Scientist Awards of $50,000 for her research to improve the speed and efficiency of a type of software that is useful in many fields such as machine learning, transportation and financial systems. Michelle’s new approach involved determining a quick approximate solution to the second-order cone programming problem, then splitting the initial cone into smaller cones, which enabled her new algorithm to greatly outperform previous approaches.
Krish Pai, 17, of Del Mar, California, received the second Regeneron Young Scientist Award of $50,000 for his machine-learning research to identify microbial genetic sequences that can be modified to biodegrade plastic. His new software, called Microby, scans databases of microorganisms and determines which ones can be changed genetically to biodegrade plastics. In tests, he identified two microorganisms that can be genetically modified to degrade plastic at a cost he believes would be ten times less than traditional recycling.
“Congratulations to the Regeneron International Science and Engineering Fair 2024 winners,” said Maya Ajmera, President and CEO, Society for Science and Executive Publisher, Science News. “I’m truly inspired by the ingenuity and determination shown by these remarkable students. Coming from around the world with diverse backgrounds and academic disciplines, these students have shown that it is possible to come together in unity to tackle some of the toughest challenges facing our world today, and I could not be prouder.”
Regeneron ISEF provides a global stage for the world’s best and brightest young scientists and engineers. Through this competition, Regeneron and the Society are fostering the next generation of STEM leaders who are pioneering solutions to improve our world. Since 2020, Regeneron has provided STEM experiences to approximately 2.4 million students, on track to meet its goal of 2.5 million by 2025.
“The talent, intelligence and potential of this year’s Regeneron ISEF finalists is truly inspiring, and I congratulate each on their remarkable achievements,” said George D. Yancopoulos, M.D., Ph.D., co-Founder, Board co-Chair, President and Chief Scientific Officer of Regeneron. “Science competitions like ISEF were pivotal in shaping my own career and fueling my passion to fight back against disease. I look forward to seeing these students continue to push the boundaries of science and technology to create positive and sustainable change for all humanity.”
Other top honors from the competition include:
Justin Huang and Victoria Ou, both 17, of Woodlands, Texas, received the Gordon E. Moore Award for Positive Outcomes for Future Generations of $50,000 for their new prototype filtration system that uses ultrasonic waves to remove microscopic plastic particles from water. In lab tests, the acoustic force from the high-frequency sound waves removed between 84% and 94% of the suspended microplastic particles in a single pass. The students are now working to scale up and fine-tune their experimental system.
Ingrid Wai Hin Chan, 17, of Hong Kong, China received the Craig R. Barrett Award for Innovation of $10,000 for her research on using a multi-sensory therapy for dementia patients. Her mixed therapy app would allow patients to practice physical and cognitive skills through a personalized, immersive environment using virtual reality headsets. Ingrid conducted an eight-week study with six people living with dementia and found that the cognitive function of patients who used her prototype improved in several areas. She believes her app could serve as a viable option for dementia patients with limited access to in-person professional therapy.
Tanishka Balaji Aglave, 15, of Valrico, Florida, received the H. Robert Horvitz Prize for Fundamental Research of $10,000 for her investigation into a natural alternative treatment against citrus greening, a disease that threatens citrus farming in many parts of the world and is currently only treated with antibiotics. Tanishka injected the trunks of infected trees with an extract from the curry leaf tree, and found through tests that this potential method could effectively and sustainably manage citrus greening disease.
Maddux Alexander Springer, 18, of Honolulu, Hawaii, received the Peggy Scripps Award for Science Communication of $10,000 for his research into fibropapillomatosis (FP), a disease that is the primary cause of death in green sea turtles. Some turtles he studied in Kaneohe Bay, Hawaii, were stricken with a disease that causes internal and external tumors that inhibit their everyday lives. After analyzing the turtles’ diet of green algae, Maddux concluded that this disease, wastewater, invasive algae and the amino acid arginine all pose a grave risk to these endangered sea creatures.
Ria Kamat, 17, of Hackensack, New Jersey; Anna Oliva, 17, of Houston, TX; and Shuhan Luo, 18, of Worcester, MA, received the Dudley R. Herschbach SIYSS Award, which provides finalists an all-expense paid trip to attend the Stockholm International Youth Science Seminar during Nobel Week in Stockholm, Sweden.
Jack Shannon, 18, of Clane, Kildare, Ireland, and Nikhil Vemuri, 17, of Cary, North Carolina, received the EU Contest for Young Scientists Award. Their projects will represent Regeneron ISEF at the EU Contest for Young Scientists to be held this September in Katowice, Poland.
For more information about the top winners and access to visual assets visit: https://www.societyforscience.org/isef-2024-media-kit.
The full list of Special Award ISEF 2024 Finalists can be found at https://www.societyforscience.org/press-release/regeneron-isef-2024-special-awards-winners.
In addition to the Top Award winners, more than 450 finalists received awards and prizes for their innovative research, including “First Award” winners, who each received a $5,000 prize.
The following lists the First Award winners for each of the 22 categories, from which the Top Awards were chosen:
Animal Sciences, sponsored by Society for ScienceMaddux Alexander Springer, Honolulu, Hawaii
Behavioral and Social Sciences, sponsored by Society for ScienceAndrew Y. Liang, San Jose, California
Biochemistry, sponsored by RegeneronAmy Hong Xiao, Garden City, New York
Biomedical and Health Sciences, sponsored by RegeneronRia Kamat, Hackensack, New Jersey; Kevin Xuan Lei, Shanghai, China
Biomedical Engineering, sponsored by Alfred E. Mann CharitiesAyush Garg, Dublin, California; Divij Motwani, Palo Alto, California; Akash Ashish Pai, Portland, Oregon
Cellular and Molecular Biology, sponsored by RegeneronLara and Maya Sarah Hammoud, Beverly Hills, Michigan
Chemistry, sponsored by Society for ScienceAkilan Sankaran, Albuquerque, New Mexico; Arjun Suresh Malpani and Siddharth Daniel D’costa, Portland, Oregon
Computational Biology and Bioinformatics, sponsored by RegeneronKun-Hyung Roh, Bronx, New York
Earth and Environmental Sciences, sponsored by Google.orgNikhil Vemuri, Durham, North Carolina; Justin Yizhou Huang and Victoria Ou, The Woodlands, Texas
Embedded Systems, sponsored by HPChloe Rae and Sophie Rose Filion, Welland, Ontario, Canada
Energy: Sustainable Materials and Design, sponsored by Siemens EnergyAlia Wahban, Hamilton, Ontario, Canada
Engineering Technology: Statics and Dynamics, sponsored by Howmet Aerospace FoundationChiyo Nakatsuji, Bunkyoku, Tokyo, Japan; Kevin Shen, Olympia, Washington
Environmental Engineering, sponsored by JacobsKrish Pai, San Diego, California; Jack Shannon, Clane, Kildare, Ireland
Materials Science, sponsored by Howmet Aerospace FoundationGrace Sun, Lexington, Kentucky
Mathematics, sponsored by Akamai FoundationAnna Oliva, Houston, Texas
Microbiology, sponsored by Schattner FoundationMatthew Chang, Irvine, California
Physics and Astronomy, sponsored by Richard F. Caris Charitable Trust IIHarini Thiagarajan and Vishal Ranganath Yalla, Bothell, Washington; Shuhan Luo, Worcester, Massachusetts
Plant Sciences, sponsored by Society for SciencePauline Estrada, Fresno, California; Tanishka Balaji Aglave, Dover, Florida
Robotics and Intelligent Machines, sponsored by RegeneronMichal Lajciak, Dubnica nad Vahom, Trenciansky kraj, Slovakia; Anthony Efthimiadis, Oakville, Ontario, Canada
Systems Software, sponsored by MicrosoftMichelle Wei, San Jose, California
Technology Enhances the Arts, sponsored by Society for ScienceAnant Khandelwal, Sritan Motati and Siddhant Sood, Alexandria, Virginia
Translational Medical Science, sponsored by RegeneronZheng-Chi Lee, West Lafayette, Indiana; Ingrid Wai Hin Chan, Hong Kong, China
The full list of all award-winning ISEF 2024 finalists is available here: https://www.societyforscience.org/press-release/regeneron-isef-2024-full-awards.
View all the finalists’ research here: https://projectboard.world/isef.
About the Regeneron International Science and Engineering FairThe Regeneron International Science and Engineering Fair (Regeneron ISEF), a program of Society for Science for over 70 years, is the world’s largest global science competition for high school students. Through a global network of local, regional and national science fairs, millions of students are encouraged to explore their passion for scientific inquiry. Each spring, a group of these students is selected as finalists and offered the opportunity to compete for approximately U.S. $9 million in awards and scholarships.
In 2019, Regeneron became the title sponsor of ISEF to help reward and celebrate the best and brightest young minds globally and encourage them to pursue careers in STEM to positively impact the world. Regeneron ISEF is supported by a community of additional sponsors, including Akamai Foundation, Alfred E. Mann Charities, Aramco, Caltech, Google.org, Gordon and Betty Moore Foundation, Howmet Aerospace Foundation, HP, , Jacobs, King Abdulaziz & his Companions Foundation for Giftedness and Creativity, Microsoft, National Geographic Society, Richard F. Caris Charitable Trust II, Rise, an initiative of Schmidt Futures and the Rhodes Trust, Schattner Foundation, Siemens Energy, Annenburg Foundation, Ballmer Group, Broadcom Foundation, Cesco Linguistic Services, Conrad N. Hilton Foundation, Edison International, Insaco, Oracle Academy, The Eli and Edythe Broad Foundation, The Ralph M. Parsons Foundation and US Army ROTC. Many are entrepreneurs across a wide range of industries. Learn more at https://www.societyforscience.org/isef/.
About Society for ScienceSociety for Science is a champion for science, dedicated to promoting the understanding and appreciation of science and the vital role it plays in human advancement. Established in 1921, Society for Science is best known for its award-winning journalism through Science News and Science News Explores, its world-class science research competitions for students, including the Regeneron Science Talent Search, the Regeneron International Science and Engineering Fair and the Thermo Fisher Scientific Junior Innovators Challenge, and its outreach and equity programming that seeks to ensure that all students have an opportunity to pursue a career in STEM. A 501(c)(3) membership organization, Society for Science is committed to inform, educate and inspire. Learn more at www.societyforscience.org and follow us on Facebook, Twitter, Instagram and Snapchat (Society4Science).
About RegeneronRegeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous approved treatments and product candidates in development, most of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases and rare diseases.
Regeneron believes that operating as a good corporate citizen is crucial to delivering on our mission. We approach corporate responsibility with three goals in mind: to improve the lives of people with serious diseases, to foster a culture of integrity and excellence and to build sustainable communities. Regeneron is proud to be included on the Dow Jones Sustainability World Index and the Civic 50 list of the most “community-minded” companies in the U.S. Throughout the year, Regeneron empowers and supports employees to give back through our volunteering, pro bono and matching gift programs. Our most significant philanthropic commitments are in the area of early science education, including the Regeneron Science Talent Search and the Regeneron International Science and Engineering Fair (ISEF).
For more information, please visit www.Regeneron.com or follow Regeneron on LinkedIn, Instagram, Facebook or X.
More information about the top winners and access to visual assets visit: https://www.societyforscience.org/isef-2024-media-kit.
Media ContactsJoseph Brown, [email protected]
Gayle Kansagor, Society for [email protected]
Photo – https://mma.prnewswire.com/media/2416174/Regeneron_ISEF_2024_Winners_Photo.jpg
Logo – https://mma.prnewswire.com/media/2416197/Society_for_Science_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/more-than-9-million-awarded-to-high-school-scientists-and-engineers-at-the-regeneron-international-science-and-engineering-fair-2024-302149316.html
Artificial Intelligence
J.P. Morgan Life Sciences Private Capital, Blue Horizon Advisors and United Al Saqer Announce Winner of Inaugural 2024 Life Sciences Innovation Summit
In conjunction with Abu Dhabi Global Healthcare Week 2024
ABU DHABI, UAE, May 17, 2024 /PRNewswire/ — J.P. Morgan Life Sciences Private Capital, Blue Horizon Advisors and United Al Saqer Group announced today Rayees Rahman of Harmonic Discovery as the winner of the inaugural J.P. Morgan Asset Management: Life Sciences Innovation Summit. Harmonic Discovery is a precision pharmacology company applying its generative chemistry platform to advance next-generation kinase inhibitors.
In partnership with the Department of Health – Abu Dhabi (DoH), the Summit took place on May 14-15, 2024 at Cleveland Clinic Abu Dhabi and showcased the 11 innovative finalists, as well as highlighted existing innovators and opportunities in the Emirate of Abu Dhabi. The event also featured keynote speeches from Dr. Laurie Glimcher of Dana-Farber Cancer Institute, Dr. Shahrukh Hashmi of the Department of Health – Abu Dhabi, and Dr. David Ho of Columbia University Medical Center and provided attendees networking opportunities to gain valuable insights into the future of life sciences innovation.
In addition, the jury designated Chun-Hao Huang of Algen Biotechnologies as honourable mention. Algen Biotechnologies is a platform therapeutics and drug discovery company using world-leading CRISPR and AI to find treatments for cancer, inflammation and metabolic diseases.
The winners were selected by an esteemed, international panel of judges, which included:Laurie Glimcher, MD, President and CEO at Dana-Farber Cancer InstituteJorge Guzman, MD, CEO at Cleveland Clinic Abu DhabiProf. Shahrukh Khurshid Hashmi, MD, Director of Research, Department of Health, Abu DhabiYasmine Hayek Kobeissi, PhD, CQF, BSc., Executive Director at Blue Horizon AdvisorsAnya Schiess, Managing Partner at J.P. Morgan Life Sciences Private CapitalWalid Zaher, PhD, Co-Founder and CEO, Carexso
Dr. Asma Al Mannaei, Executive Director of the Research and Innovation Centre at the Department of Health – Abu Dhabi said: “Under the directives of the UAE’s wise leadership, and renowned for its world-leading medical infrastructure, Abu Dhabi stands at the forefront of healthcare excellence, offering an unparalleled opportunity for advancement in healthcare for global partners. It was our utmost pleasure hosting the J.P. Morgan Asset Management Life Sciences Innovation Summit 2024 on the sidelines of Abu Dhabi Global Healthcare Week and we commend the winners for their pioneering efforts in driving impactful advancements in healthcare; their dedication to innovation not only transforms the landscape of medicine, but also holds the promise of improving lives worldwide.”
Stephen Squinto, PhD, Chief Investment Officer, J.P. Morgan Life Sciences Private Capital said: “We are thrilled with the level of biotech passion and innovation that we observed at this year’s Summit in Abu Dhabi. The energy was truly palpable we are thrilled to announce Rayees Rahman as the winner of our first Life Sciences Innovation Summit. Harmonic Discovery’s approach embodies the next generation of drug discovery and development. We appreciate the time and effort of all participants and cannot wait for our next event in the region.”
Nabil Kobeissi, Chief Executive Officer of Blue Horizon Advisors, said: “As the main sponsor, we are committed to nurturing and fostering the growth of all 11 finalists in this vibrant biotech ecosystem. This Summit marks the beginning of a transformative journey, and we are confident that it will pave the way for a flourishing hub in the region. We are also pleased to announce that we will commit to invest in and partner with the winner, Harmonic Discovery, to support its future growth in the region.”
Sponsors for the event included J.P. Morgan Life Sciences Private Capital, J.P. Morgan Commercial Bank, Blue Horizon Advisors, United Al Saqer Group, Thermo Fisher Scientific, and Salam Capital. The Summit organisation, logistics and finalist recruitment were facilitated by Lyfebulb.
Of importance, at the Summit, Mr. Mohamed Al Breiki, Executive Director of Sustainable Development at Masdar City, announced that Masdar City Free Zone would award all 11 Finalists complimentary business licenses to further support their establishment in the region. Masdar City is one of the world’s most sustainable urban developments and innovation hubs with a growing focus on life science entrepreneurship in Abu Dhabi.
View original content:https://www.prnewswire.co.uk/news-releases/jp-morgan-life-sciences-private-capital-blue-horizon-advisors-and-united-al-saqer-announce-winner-of-inaugural-2024-life-sciences-innovation-summit-302149186.html
Artificial Intelligence
Congregating in the Lion City for a Win-Win Future of Intelligent Computing at the Global Data Center Facility Summit 2024
SINGAPORE, May 17, 2024 /PRNewswire/ — On May 17, 2024, the Global Data Center Facility Summit 2024 was held in Singapore with the theme of “Power the Digital Era Forward.” At the summit, over 600 data center industry leaders, technical experts, and ecosystem partners gathered to discuss new trends and opportunities of the global data center industry in the intelligent computing era. The attendees also got to experience all-scenario, all-ecosystem, and all-service end-to-end (E2E) solutions, share innovative practices of green data centers in the Asia Pacific and Europe, and experience the exhibition vehicle to unveil the mystery of Outdoor PowerPOD that features one power system per container. By fully embracing the intelligent computing era, Huawei strives to power the digital era forward.
Seizing Opportunities Brought by AI and Jointly Building Green & Reliable Computing Infrastructure
At the opening speech, Charles Yang, Senior Vice President of Huawei and President of Marketing, Sales and Services, Huawei Digital Power, noted that since ChatGPT ushered in the AI era, large models keep pushing the limits of computing power and the intelligent computing industry is witnessing an unprecedented construction boom. As predicted, 100 GW will be added to the global data center installed capacity and the market value will exceed US$600 billion in the next five years.
According to Charles, with opportunities come challenges. The primary challenge concerning the data center industry is reliability and electricity. Data centers are scaling up from the MW-level to the GW-level. E2E reliability of data centers is becoming even more important than ever. In response to the opportunities, Huawei will work with customers and partners to expand the industry space.
Steering Data Centers to the AI Era with Product + Service + Ecosystem
During the summit, Sun Xiaofeng, President of Huawei Data Center Facility & Critical Power Business, delivered a speech titled “Power the Digital Era Forward. ” He stated that as AI large models are penetrating, the surging compute demands drive the expansive growth in data center.
To address the challenges, Huawei strives to build product + service + ecosystem E2E data center solutions that feature fast deployment, flexible cooling, green energy, and ultimate reliability.
Fast deployment: Data centers are fully modularized and prefabricated to ensure high quality and efficient construction.Flexible cooling: Air-liquid fusion and integrated cooling source emerges as the optimal cooling architecture for intelligent computing.Green energy: New generation-grid-load-storage integrated solution is built to ensure the sound operations of intelligent computing centers.Ultimate reliability: Data centers are safeguarded through reliable products and preventive protection.Currently, Huawei’s global service network covers more than 170 countries with over 1800 professional engineers, providing 24/7 technical support. With N+ flagship service centers, Huawei has built a one-hour service radius for its customers.
The ecosystem is a key part for a win-win future of intelligent computing. Huawei works with partners to develop comprehensive E2E solutions and provide customers with one-stop data center services.
During the summit, Huawei and the ASEAN Centre for Energy released a white paper on “Building Next Generation Data Center Facility in ASEAN.” The document provides insights into the status quo, challenges, and trends of data centers in the ASEAN region, and emphasizes that efficient and energy-saving products and solutions should be applied. It also proposes future-oriented policy recommendations for data center markets.
In the ecosystem exhibition area, Huawei showcased scenario-based solutions for large-, medium-, and small-sized data centers, and demonstrated data center consulting, design, integrated development, and delivery capabilities with dozens of ecosystem partners including CIMC, Weichai, CSCEC, and Huashi.
On a special note, the Huawei Outdoor PowerPOD exhibition vehicle made its global debut. The Huawei Outdoor PowerPOD features one power system per container, outdoor deployment, plug-and-play, and high protection rating and reliability. It has become the preferred choice for decoupling the power supply architecture.
A single tree cannot make a forest.
AI is presenting great opportunities. By delving into the industry, aggregating partner ecosystems, and making innovations applicable to transformations, Huawei will continue to help customers build reliable computing infrastructure, accelerating the industry to embrace AI and powering the digital era forward.
Photo – https://mma.prnewswire.com/media/2415818/Global_Data_Center_Facility_Summit_2024.jpg
View original content:https://www.prnewswire.co.uk/news-releases/congregating-in-the-lion-city-for-a-win-win-future-of-intelligent-computing-at-the-global-data-center-facility-summit-2024-302148973.html
-
Uncategorized6 days agoCrossover Markets Becomes First Crypto ECN to Integrate with Talos
-
Artificial Intelligence6 days agoMSI Highlights Optimized AI Platforms to Accelerate Compute-Intensive Applications at ISC 2024
-
Artificial Intelligence6 days agoAdvanced HPC Server Platforms by MiTAC and TYAN Spotlighted at ISC High Performance 2024
-
Uncategorized6 days ago
Precisely Showcases Critical Role of Trusted Data in AI at the Gartner® Data & Analytics Summit in London
-
Uncategorized5 days ago
Artificial intelligence tool detects sex-related differences in brain structure
-
Artificial Intelligence3 days agoStrava Unveils New Chapter of Accelerated Product Development at Brand’s Flagship Event
-
Uncategorized6 days ago
Electric 3 wheeler Market worth $1.5 billion by 2030 | MarketsandMarkets
-
Artificial Intelligence6 days agoLG CEO EMBARKS ON STRATEGIC U.S. VISIT TO ENHANCE AI INITIATIVES
